Table 5 Treatment practices of UMPs particularly for malaria
Variables | N = 140 |
|---|---|
n (%) | |
Total length (mean ± SD) of medical practice (year) | 8.3 ± 3.1 |
Attended any training programme | 125 (89.3) |
Training provided by govt. agency | 40 (28.6) |
Training period (months) (mean ± SD) | 7.3 ± 3.5 |
Training on malaria diagnosis and treatment | 6 (4.3) |
Major common diseases in area | |
Malaria | 136 (97.1) |
Diarrhoea | 57 (40.7) |
Skin disease | 11 (7.9) |
Cough cold | 35 (25.0) |
Typhoid | 6 (4.3) |
Tuberculosis | 8 (5.7) |
Viral Fever | 9 (6.4) |
Jaundice | 2 (1.4) |
Providing services on following health issues | |
Maternal health care | 72 (51.4) |
Child health care | 106 (75.7) |
Family planning | 124 (88.6) |
Vaccination | 111 (79.3) |
Common diseases (diarrhoea, skin diseases, typhoid, piles, asthma) | 140 (100.0) |
Malaria | 138 (98.6) |
Tuberculosis | 5 (3.6) |
No. of patients treated in last week (mean ± SD) | 47.3 ± 34.9 |
No. of fever cases treated in last week (mean ± SD) | 27.4 ± 24.7 |
No. of malaria patient treated in last week (mean ± SD) | 17.6 ± 5.8 |
Usually treat suspected malaria cases based on clinical symptoms | 53 (37.9) |
Treat suspected malaria cases only after blood test using RDTs | 87 (62.1) |
Having malaria RDT in stock (physically verified) | 127 (90.7) |
Source of RDT procured | |
Market | 137 (97.9) |
Government Hospital/ASHAs | 2 (1.4) |
Source of antimalarial procured | |
Market | 138 (98.6) |
Government hospital/ASHAs | 2 (1.4) |
Mode of treatment preferred | |
Injectable | 94 (67.1) |
Oral (tablets/syrup) | 15 (10.7) |
Both | 31 (22.1) |
Cause of preference of injectable | |
Patient psychology (client’s preference) | 103 (73.6) |
Fast recovery (provider’s preference) | 37 (26.4) |
Treated complicated/serious malaria patient | 6 (4.3) |
Heard about national diagnosis and treatment guidelines of malaria | 12 (8.6) |
Treatment practices of malaria patients | |
E-Mal (artesunate injection) | |
P. falciparum | 95 (67.9) |
P. vivax | 17 (12.1) |
Quinine tablets | |
P. falciparum | 2 (1.4) |
P. vivax | 3 (2.1) |
Quinine injection | |
P. falciparum | 2 (1.4) |
P. vivax | 2 (1.4) |
Chloroquine tablets | |
P. falciparum | 18 (12.9) |
P. vivax | 31 (22.1) |
Chloroquine injection | |
P. falciparum | 11 (7.9) |
P. vivax | 33 (23.6) |
Primaquine tablets | |
P. falciparum | 25 (17.9) |
P. vivax | 7 (5.0) |